Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing
- PMID: 9626049
- PMCID: PMC1858442
Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing
Abstract
Angiogenesis is an essential component of normal wound repair, yet the primary mediators of wound angiogenesis have not been well described. The current study characterizes the contribution of vascular endothelial cell growth factor (VEGF) to the angiogenic environment of human surgical wounds. Surgical wound fluid samples (n = 70) were collected daily for up to 7 postoperative days (POD) from 14 patients undergoing mastectomy or neck dissection. VEGF levels in surgical wound fluid were lowest on POD 0, approximating values of serum, but increased steadily through POD 7. An opposite pattern was noted for basic fibroblast growth factor-2. Fibroblast growth factor-2, which has been previously described as a wound angiogenic factor, exhibited highest levels at POD 0, declining to near serum levels by POD 3. Surgical wound fluid form all time points stimulated marked endothelial cell chemotaxis and induced a brisk neovascular response in the rat corneal micropocket angiogenesis assay. Antibody neutralization of VEGF did not affect the in vitro chemotactic or the in vivo angiogenic activity early wound samples (POD 0). In contrast, VEGF neutralization significantly attenuated both chemotactic activity (mean decrease 76 +/- 13%, P < 0.01) and angiogenic activity (5 of 5 samples affected) of later wound samples (POD 3 and 6). The results suggest a model of wound angiogenesis in which an initial angiogenic stimulus is supplied by fibroblast growth factor-2, followed by a subsequent and more prolonged angiogenic stimulus mediated by VEGF.
Similar articles
-
Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation.J Surg Res. 2001 Apr;96(2):173-82. doi: 10.1006/jsre.2001.6089. J Surg Res. 2001. PMID: 11266270
-
A novel in vitro assay for human angiogenesis.Lab Invest. 1996 Oct;75(4):539-55. Lab Invest. 1996. PMID: 8874385
-
Differential angiogenic and proliferative activity of surgical and burn wound fluids.J Trauma. 2003 Jun;54(6):1205-10; discussion 1211. doi: 10.1097/01.TA.0000061884.28845.5A. J Trauma. 2003. PMID: 12813345
-
Molecular control of physiological skin angiogenesis.Eur J Dermatol. 2002 Nov-Dec;12(6):VII-X. Eur J Dermatol. 2002. PMID: 12506892 Review. No abstract available.
-
Angiogenesis and angiogenesis inhibition: an overview.EXS. 1997;79:1-8. doi: 10.1007/978-3-0348-9006-9_1. EXS. 1997. PMID: 9002217 Review. No abstract available.
Cited by
-
Cell migration.Compr Physiol. 2012 Oct;2(4):2369-92. doi: 10.1002/cphy.c110012. Compr Physiol. 2012. PMID: 23720251 Free PMC article. Review.
-
Integrin-mediated regulation of epidermal wound functions.Cell Tissue Res. 2016 Sep;365(3):467-82. doi: 10.1007/s00441-016-2446-2. Epub 2016 Jun 28. Cell Tissue Res. 2016. PMID: 27351421 Free PMC article. Review.
-
Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis.Cancers (Basel). 2021 Feb 24;13(5):942. doi: 10.3390/cancers13050942. Cancers (Basel). 2021. PMID: 33668160 Free PMC article. Review.
-
Umbilical cord-derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: From mechanism to therapeutics.Cell Prolif. 2024 Apr;57(4):e13586. doi: 10.1111/cpr.13586. Epub 2023 Dec 26. Cell Prolif. 2024. PMID: 38148579 Free PMC article. Review.
-
Collagen/hyaluronan based hydrogels releasing sulfated hyaluronan improve dermal wound healing in diabetic mice via reducing inflammatory macrophage activity.Bioact Mater. 2021 Apr 30;6(12):4342-4359. doi: 10.1016/j.bioactmat.2021.04.026. eCollection 2021 Dec. Bioact Mater. 2021. PMID: 33997511 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources